Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31 3 months ending 2013-09-30
Revenue 14.97 10.61 15.96 14.74 13.01
Other Revenue, Total - - - - -
Total Revenue 14.97 10.61 15.96 14.74 13.01
Cost of Revenue, Total 1.50 1.19 2.45 1.32 2.54
Gross Profit 13.48 9.42 13.51 13.42 10.47
Selling/General/Admin. Expenses, Total 6.74 5.24 5.07 4.42 4.76
Research & Development 3.02 2.69 3.13 2.37 2.41
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.18 0.14 0.20 0.20 0.23
Other Operating Expenses, Total - - - - -
Total Operating Expense 11.44 9.25 10.86 8.31 9.94
Operating Income 3.53 1.36 5.10 6.42 3.07
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -2.63 0.06 -2.70 -4.10 -0.65
Income Before Tax 0.90 1.24 2.15 2.01 2.02
Income After Tax 0.78 1.29 2.10 1.87 1.97
Minority Interest 0.50 0.30 0.00 - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items 1.28 1.59 2.10 1.87 1.97
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 1.28 1.59 2.10 1.87 1.97
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 1.28 1.59 2.10 1.87 1.97
Income Available to Common Incl. Extra Items 1.28 1.59 2.10 1.87 1.97
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 - 0.00 - -
Diluted Weighted Average Shares 21.35 21.78 21.78 21.29 20.84
Diluted EPS Excluding Extraordinary Items 0.06 0.07 0.10 0.09 0.09
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue - 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.07 0.08 0.11 0.10 0.10